← Back to Search

Behavioral Intervention

Risk Assessment for Health Risks (GRACE Trial)

N/A
Recruiting
Led By Lori Orlando, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study completion, expected 1 year from study start
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to develop a program called "GRACE" to help assess and manage health risks in populations with limited resources. The goal is to improve health outcomes, quality of life, and reduce costs

Who is the study for?
The GRACE trial is for patients with conditions like hyperthermia, liver disease, cardiovascular disease, cancer, or risk of heat stroke. It's also for their healthcare providers and family members who might have genetic risks. Participants should be willing to use a web-based platform to enter health history and may need to undergo genetic testing if advised.
What is being tested?
GRACE aims to develop a framework for genomic medicine risk assessment that can work even in low-resource settings. The study will test how well this approach helps people understand their health risks based on genetics and improve patient outcomes through better-informed guidelines.
What are the potential side effects?
Since the intervention involves risk assessment rather than medication or procedures, traditional side effects are not expected. However, participants may experience stress or anxiety from learning about their genetic risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study completion, expected 1 year from study start
This trial's timeline: 3 weeks for screening, Varies for treatment, and at study completion, expected 1 year from study start for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Reach of genomic risk assessment
Uptake of genetic counseling risk recommendations by the participant
Uptake of genetic testing recommendations by the provider
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: InterventionExperimental Treatment1 Intervention
Risk assessment pipeline

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,110 Total Patients Enrolled
4 Trials studying Hyperthermia
5,850 Patients Enrolled for Hyperthermia
National Human Genome Research Institute (NHGRI)NIH
270 Previous Clinical Trials
293,319 Total Patients Enrolled
1 Trials studying Hyperthermia
5,000 Patients Enrolled for Hyperthermia
Lori Orlando, MDPrincipal InvestigatorDuke University
2 Previous Clinical Trials
3,620 Total Patients Enrolled
Alexander S Parker, PhDPrincipal InvestigatorUniversity of Florida
1 Previous Clinical Trials
~375 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top